In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
The price of Nurix Therapeutics Inc (NASDAQ: NRIX) closed at $9.69 in the last session, down -7.80% from day before closing price of $10.51. In other words, the price has decreased by -$7.80 from its previous closing price. On the day, 1.49 million shares were traded. NRIX stock price reached its highest trading level at $10.5 during the session, while it also had its lowest trading level at $9.45.
Ratios:
We take a closer look at NRIX’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 6.46 and its Current Ratio is at 6.46. In the meantime, Its Debt-to-Equity ratio is 0.05 whereas as Long-Term Debt/Eq ratio is at 0.04.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Leerink Partners on March 17, 2025, initiated with a Market Perform rating and assigned the stock a target price of $16.
On December 10, 2024, BTIG Research started tracking the stock assigning a Buy rating and target price of $35.
On December 06, 2024, BMO Capital Markets started tracking the stock assigning a Outperform rating and target price of $35.BMO Capital Markets initiated its Outperform rating on December 06, 2024, with a $35 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Mar 03 ’25 when van Houte Hans sold 5,825 shares for $14.49 per share. The transaction valued at 84,388 led to the insider holds 33,724 shares of the business.
JOHANNES VAN HOUTE bought 5,825 shares of NRIX for $89,996 on Mar 03 ’25. On Jan 31 ’25, another insider, Ring Christine, who serves as the Chief Legal Officer of the company, sold 5,760 shares for $19.95 each. As a result, the insider received 114,934 and left with 32,538 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, NRIX now has a Market Capitalization of 738722944 and an Enterprise Value of 154063264. For the stock, the TTM Price-to-Sale (P/S) ratio is 13.54 while its Price-to-Book (P/B) ratio in mrq is 1.40. Its current Enterprise Value per Revenue stands at 2.824 whereas that against EBITDA is -0.751.
Stock Price History:
The Beta on a monthly basis for NRIX is 2.24, which has changed by -0.2978261 over the last 52 weeks, in comparison to a change of -0.024663687 over the same period for the S&P500. Over the past 52 weeks, NRIX has reached a high of $29.56, while it has fallen to a 52-week low of $10.21. The 50-Day Moving Average of the stock is -37.47%, while the 200-Day Moving Average is calculated to be -53.04%.
Shares Statistics:
According to the various share statistics, NRIX traded on average about 823.87K shares per day over the past 3-months and 1116260 shares per day over the past 10 days. A total of 75.87M shares are outstanding, with a floating share count of 74.72M. Insiders hold about 1.99% of the company’s shares, while institutions hold 108.19% stake in the company. Shares short for NRIX as of 1741910400 were 12168982 with a Short Ratio of 14.77, compared to 1739491200 on 11361295. Therefore, it implies a Short% of Shares Outstanding of 12168982 and a Short% of Float of 17.119999999999997.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
